BILL (NYSE: BILL) and Billtrust today announced they have launched the first live pilot to enable trusted AI agents to ...

The presentations cover two FDA-approved antibiotics marketed by Innoviva Specialty Therapeutics, ceftobiprole (ZEVTERA ®) and zoliflodacin (NUZOLVENCE ® ), and represent the company’s ongoing ...

For those who have memorized the knowledge of infectious disease laws, antimicrobial drugs, and pathogens, but still mix up ...

Delve Bio launched Delve Detect Plasma, a blood-based mNGS assay that detects over 68,000 pathogens with next-day results, ...

Pediatricians are urging parents to prepare for RSV and other winter illnesses, emphasizing the specific risks for infants.

When verifying posts claiming that Russian authorities denied as "fake documents" the tightening of regulations following a ...

Moscow urged to disclose details of suspected outbreak amid growing scepticism of the official version of events ...

Through long-standing research, which has been supported by the National Institutes of Health, investigators at Johns Hopkins ...

An AI experiment gone wrong: at the Fortune AIQ Summit, Future Today Strategy Group CEO Amy Webb recalled accidentally sending messages to 1,000 people after a coding loop went wrong. Trump repeatedly ...

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced its ...

Analyzing data from the Global Cancer Observatory's Cancer Today (GLOBOCAN) database, the authors estimate 2.3 million new cancer cases in 2024 were associated with infection. That equates to 12 ...